{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:22:31Z","timestamp":1794266551937,"version":"4.9.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["9039-00360B"],"award-info":[{"award-number":["9039-00360B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008208","name":"Chief Physician Johan Boserup and Lise Boserups Scholarship","doi-asserted-by":"publisher","award":["20795-24"],"award-info":[{"award-number":["20795-24"]}],"id":[{"id":"10.13039\/501100008208","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","award":["MC_UU_00032"],"award-info":[{"award-number":["MC_UU_00032"]}],"id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.atherosclerosis.2025.120605","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:35:23Z","timestamp":1764088523000},"page":"120605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons"],"prefix":"10.1016","volume":"412","author":[{"given":"Mia \u00d8.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Vedel-Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune F.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120605_bib1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Boren","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2025.120605_bib3","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120605_bib5","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.111.088591","article-title":"Determinants of residual risk in secondary prevention patients treated with high- versus low-dose Statin therapy: the treating to new targets (TNT) study","volume":"125","author":"Mora","year":"2012","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.120605_bib6","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2015.03.544","article-title":"Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins","volume":"65","author":"Schwartz","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120605_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCOUTCOMES.115.002104","article-title":"Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease: twenty-two-year Follow-Up of the bezafibrate infarction prevention study and registry","volume":"9","author":"Klempfner","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120605_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005549","article-title":"Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low-density lipoprotein cholesterol","volume":"6","author":"Lawler","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007402","article-title":"Residual risk of atherosclerotic cardiovascular events in relation to reductions in very-low-density lipoproteins","volume":"6","author":"Lawler","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120605_bib11","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2024.07.034","article-title":"Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using Non-HDL cholesterol","volume":"84","author":"Bjornson","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120605_bib12","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.120605_bib13","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120605_bib14","first-page":"1129","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2025.120605_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","article-title":"A test in context: lipid profile, fasting versus nonfasting","volume":"70","author":"Nordestgaard","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120605_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Boren","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cll.2006.07.004","article-title":"Cholesterol profile measurement by vertical auto profile method","volume":"26","author":"Kulkarni","year":"2006","journal-title":"Clin Lab Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"issue":"23 Suppl 1","key":"10.1016\/j.atherosclerosis.2025.120605_bib19","first-page":"III2","article-title":"Atherogenic lipoprotein particles in atherosclerosis","volume":"109","author":"Carmena","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2025.120605_bib21","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the european atherosclerosis society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120605_bib22","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/ATVBAHA.111.226100","article-title":"Triglycerides and heart disease: still a hypothesis?","volume":"31","author":"Goldberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fendo.2020.00252","article-title":"Causes and consequences of hypertriglyceridemia","volume":"11","author":"Packard","year":"2020","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/41.1.153","article-title":"Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins","volume":"41","author":"Zilversmit","year":"1995","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinchem\/hvaa296","article-title":"Triglyceride-rich lipoprotein remnants and cardiovascular disease","volume":"67","author":"Duran","year":"2021","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120605_bib27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0022-2275(20)38428-5","article-title":"Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits","volume":"29","author":"Nordestgaard","year":"1988","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.8.4.421","article-title":"Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall","volume":"8","author":"Nordestgaard","year":"1988","journal-title":"Arteriosclerosis"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120605_bib29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120605_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.11.3.569","article-title":"Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans","volume":"11","author":"Shaikh","year":"1991","journal-title":"Arterioscler Thromb"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.15.4.534","article-title":"Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media","volume":"15","author":"Nordestgaard","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9943","key":"10.1016\/j.atherosclerosis.2025.120605_bib32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040522","article-title":"The role of macrophages in the pathogenesis of atherosclerosis","volume":"12","author":"Blagov","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00041433-200210000-00001","article-title":"Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis","volume":"13","author":"Proctor","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120605_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2018.294926","article-title":"Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population","volume":"65","author":"Hansen","year":"2019","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120605_bib37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1194\/jlr.R700001-JLR200","article-title":"Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase","volume":"48","author":"Zheng","year":"2007","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120605_bib38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.ATV.18.3.458","article-title":"Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes","volume":"18","author":"Moyer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2025.120605_bib39","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/01.ATV.19.10.2474","article-title":"Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins","volume":"19","author":"Cohn","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120605_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1194\/jlr.M700505-JLR200","article-title":"Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation","volume":"50","author":"Wang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.993633","article-title":"Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: implications for disease progression and mechanistic insights","volume":"9","author":"Lee","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2025.120605_bib42","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/cvr\/cvad177","article-title":"Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance","volume":"119","author":"Packard","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2025.120605_bib43","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120605_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: a postprandial phenomenon","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2025.120605_bib45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1440-1681.1997.tb01822.x","article-title":"Is atherosclerosis exclusively a postprandial phenomenon?","volume":"24","author":"Mamo","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120605_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac783","article-title":"What is 'remnant cholesterol'?","author":"Sturzebecher","year":"2023","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacl.2021.09.046","article-title":"Lipid measurements in the management of cardiovascular diseases: practical recommendations a scientific statement from the national lipid association writing group","volume":"15","author":"Wilson","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120605_bib49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamacardio.2018.1533","article-title":"Comparison of low-density lipoprotein cholesterol assessment by martin\/hopkins estimation, friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER trial","volume":"3","author":"Martin","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib51","series-title":"Lipids and lipoproteins. Tietz textbook of laboratory medicine","author":"Meeusen","year":"2022"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2025.120605_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti Apo B-100 and anti Apo A-I immunoaffinity mixed gels","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120605_bib53","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1194\/jlr.D300003-JLR200","article-title":"Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent","volume":"44","author":"Hirowatari","year":"2003","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)30123-1","article-title":"A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC","volume":"43","author":"Usui","year":"2002","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/clinchem\/48.5.737","article-title":"Highly sensitive cholesterol assay with enzymatic cycling applied to measurement of remnant lipoprotein-cholesterol in serum","volume":"48","author":"Kishi","year":"2002","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120605_bib56","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","article-title":"Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population","volume":"61","author":"Varbo","year":"2015","journal-title":"Clin Chem"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2025.120605_bib57","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in normal weight, overweight, and Obese individuals from the copenhagen general population study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"},{"issue":"3\u20134","key":"10.1016\/j.atherosclerosis.2025.120605_bib59","first-page":"171","article-title":"Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy","volume":"48","author":"Otvos","year":"2002","journal-title":"Clin Lab"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2025.120605_bib60","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.109.864124","article-title":"Letter by Ala-Korpela et al regarding article, \"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women\"","volume":"120","author":"Ala-Korpela","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib61","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2025.120605_bib62","article-title":"A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data","volume":"8","author":"Vehtari","year":"2007","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2020.03.028","article-title":"Reply to: \"methodological issues regarding: \"A third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals\"\"","volume":"302","author":"Wurtz","year":"2020","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120605_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jacl.2022.02.007","article-title":"Concerns regarding NMR lipoprotein analyses performed on the nightingale heath platform - focus on LDL subclasses","volume":"16","author":"Krauss","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0021-9150(88)90060-3","article-title":"Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis","volume":"72","author":"Nordestgaard","year":"1988","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120605_bib67","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1373\/clinchem.2007.100586","article-title":"Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis","volume":"54","author":"Caulfield","year":"2008","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12944-020-01311-w","article-title":"Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance","volume":"19","author":"Chen","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2025.120605_bib69","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.jacc.2020.09.610","article-title":"VLDL cholesterol accounts for one-half of the risk of myocardial infarction associated with apoB-Containing lipoproteins","volume":"76","author":"Balling","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2025.120605_bib70","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120605_bib71","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.ATV.0000173310.85845.7b","article-title":"Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu heart study","volume":"25","author":"Imke","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002765","article-title":"Remnant lipoprotein cholesterol and incident coronary heart disease: the Jackson heart and framingham offspring cohort studies","volume":"5","author":"Joshi","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120605_bib73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacc.2018.04.050","article-title":"Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease","volume":"72","author":"Saeed","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120605_bib74","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2025.120605_bib75","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Castaner","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib76","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/clinchem\/hvaa290","article-title":"Very low-density lipoprotein cholesterol may mediate a substantial component of the effect of obesity on myocardial infarction risk: the copenhagen general population study","volume":"67","author":"Johansen","year":"2021","journal-title":"Clin Chem"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2025.120605_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10153388","article-title":"The effects of calculated remnant-like particle cholesterol on incident cardiovascular disease: insights from a general Chinese population","volume":"10","author":"Chen","year":"2021","journal-title":"J Clin Med"},{"issue":"42","key":"10.1016\/j.atherosclerosis.2025.120605_bib78","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120605_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019140","article-title":"Small dense low-density lipoprotein cholesterol is the Most atherogenic lipoprotein parameter in the prospective framingham offspring study","volume":"10","author":"Ikezaki","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib80","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jnc.15659","article-title":"Circulating metabolites associated with incident myocardial infarction and stroke: a prospective cohort study of 90 438 participants","volume":"162","author":"Guo","year":"2022","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120605_bib81","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jacl.2022.09.005","article-title":"Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the multi-ethnic study of atherosclerosis (MESA)","volume":"16","author":"Chevli","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2025.120605_bib82","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/eurheartj\/ehab705","article-title":"Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study","volume":"43","author":"Wadstrom","year":"2022","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120605_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100653","article-title":"Triglyceride-rich lipoproteins cholesterol, 10-years atherosclerotic cardiovascular disease risk, and risk of myocardial infarction and ischemic stroke","volume":"65","author":"Jia","year":"2024","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120605_bib84","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","article-title":"Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: copenhagen general population study","volume":"41","author":"Johansen","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib85","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120605_bib86","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120605_bib87","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib88","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2003.09.074","article-title":"Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus","volume":"43","author":"Fukushima","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120605_bib89","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1194\/jlr.RA120000746","article-title":"Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease","volume":"61","author":"Cao","year":"2020","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.13059","article-title":"Contribution of remnant cholesterol to cardiovascular risk","volume":"288","author":"Langsted","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2021.06.907","article-title":"Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status","volume":"330","author":"Liu","year":"2021","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12933-020-01076-7","article-title":"The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes","volume":"19","author":"Cao","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib93","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12933-022-01667-6","article-title":"Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study","volume":"21","author":"Huh","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120605_bib94","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2337\/dc21-2511","article-title":"Remnant cholesterol and its visit-to-visit variability predict cardiovascular outcomes in patients with type 2 diabetes: findings from the ACCORD cohort","volume":"45","author":"Fu","year":"2022","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120605_bib95","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","article-title":"Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with CKD","volume":"73","author":"Bajaj","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120605_bib96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.07320619","article-title":"Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD","volume":"15","author":"Lamprea-Montealegre","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib97","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1161\/ATVBAHA.124.321387","article-title":"Impaired renal function with higher remnant cholesterol related to risk of atherosclerotic cardiovascular disease: a cohort study","volume":"44","author":"Elias-Lopez","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120605_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119241","article-title":"Association of low-grade inflammation and elevated remnant cholesterol with risk of ASCVD and mortality in impaired renal function","volume":"406","author":"Elias-Lopez","year":"2025","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120605_bib99","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1039\/b910205a","article-title":"High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism","volume":"134","author":"Soininen","year":"2009","journal-title":"Analyst"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120605_bib100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120605_bib101","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts","volume":"131","author":"Wurtz","year":"2015","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2025.120605_bib102","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/CIRCULATIONAHA.115.016857","volume":"132","author":"Mora","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib103","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1373\/clinchem.2016.264515","article-title":"Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women","volume":"63","author":"Lawler","year":"2017","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120605_bib104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/1354750X.2020.1731762","article-title":"High-frequency metabolite profiling and the incidence of recurrent cardiac events in patients with post-acute coronary syndrome","volume":"25","author":"Vroegindewey","year":"2020","journal-title":"Biomarkers"},{"issue":"39","key":"10.1016\/j.atherosclerosis.2025.120605_bib105","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/eurheartj\/ehad337","article-title":"Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK biobank study","volume":"44","author":"Bjornson","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib106","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/clinchem\/hvae222","article-title":"Small remnants versus large triglyceride-rich lipoproteins in risk of atherosclerotic cardiovascular disease","volume":"71","author":"Wadstrom","year":"2025","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120605_bib107","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2337\/dbi19-0007","article-title":"Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease","volume":"69","author":"Chait","year":"2020","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib108","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-023-06016-0","article-title":"Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study","volume":"66","author":"Wadstrom","year":"2023","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120605_bib109","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11892-024-01555-1","article-title":"Impact of remnant cholesterol on cardiovascular risk in diabetes","volume":"24","author":"Elias-Lopez","year":"2024","journal-title":"Curr Diabetes Rep"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025015035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025015035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:26:20Z","timestamp":1781270780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025015035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":109,"alternative-id":["S0021915025015035"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120605","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120605"}}